STOCKHOLDERS EQUITY (DEFICIT) (Details 3) - Registered Warrant |
6 Months Ended |
|---|---|
|
Jun. 30, 2022
$ / shares
shares
| |
| Number of options outstanding | 2,975,497 |
| Weighted average remaining contractual life (in years) | 3 years 10 months 20 days |
| Number of exercisable options | 2,975,497 |
| Weighted average exercise price exercisable | $ / shares | $ 5.50 |
| 5.50 | |
| Number of options outstanding | 2,975,497 |
| Weighted average remaining contractual life (in years) | 3 years 10 months 20 days |
| Number of exercisable options | 2,975,497 |
| Weighted average exercise price exercisable | $ / shares | $ 5.50 |
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|